Concepedia

Roland Heckendorn

RH

Statistics

Publications

12

Citations

1.2K

H-Index

11

Active since

1973

Affiliations

Novartis (Switzerland)(Current)

University of Zurich

Max Planck Society

Max Planck Institute for Medical Research

Roland Heckendorn is an author at Novartis (Switzerland) specializing in organic chemistry, chemistry, and medicine.

Top concepts

Publications per year

1973–2007

12

Publications

12

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

F. Gasparini, Kurt Lingenhöhl, Natacha Stoehr et al. · Neuropharmacology · 1999 · 720 citations

, , +7

CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐<scp>d</scp>‐aspartate receptor antagonists with oral activity

Graham E. Fagg, H.‐R. Olpe, M.F. Pozza et al. · British Journal of Pharmacology · 1990 · 188 citations · Full text

, , +15

The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents

Markus Schmutz, Ch. Portet, A. Jeker et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1990 · 137 citations

, , +11

Differentiation of Glycine Antagonist Sites ofN-Methyl-d-aspartate Receptor Subtypes

Michael Honer, Dietmar Benke, Bodo Laube et al. · Journal of Biological Chemistry · 1998 · 53 citations · Full text

Molecular distinction of three N-methyl-D-aspartate-receptor subtypes in situ and developmental receptor maturation demonstrated with the photoaffinity ligand 125I-labeled CGP 55802A.

Thomas M. Marti, Dietmar Benke, S. Mertens et al. · Proceedings of the National Academy of Sciences · 1993 · 31 citations · Full text

, , +25

1–5 of 12